Cancer patients happier getting immunotherapy at home?

NCT ID NCT06163053

Completed Knowledge-focused Sponsor: Bristol-Myers Squibb Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This French study asked 49 cancer patients how they felt about switching from hospital to home-based immunotherapy. The goal was to see if home treatment improved their satisfaction with care. It was an observational study, meaning no new treatments were tested—just patient experiences were tracked.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Immunotherapy (immune checkpoint inhibitors)
What this could lead to: If successful, this could show that giving immunotherapy at home is a viable option, potentially improving patient comfort and quality of life.
What could go wrong: This is a small, observational study in France, so results may not apply to other settings or treatments. It measures satisfaction, not safety or effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER SOLID TUMORS

Contacts and locations

Locations

CH Francois Quesnay

Mantes-la-Jolie, 78200, France
CH Metropole Savoie

Chambéry, 73011, France
CH de Pau

Pau, 64046, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.